Navigation Links
Safety of nanoparticles in food crops is still unclear
Date:6/1/2011

With the curtain about to rise on a much-anticipated new era of "nanoagriculture" using nanotechnology to boost the productivity of plants for food, fuel, and other uses scientists are reporting a huge gap in knowledge about the effects of nanoparticles on corn, tomatoes, rice and other food crops. Their article appears in ACS' Journal of Agricultural and Food Chemistry.

Jorge Gardea-Torresdey and colleagues at The University of Texas at El Paso, a co- investigator for the NSF/EPA University of California Center for Environmental Implications of Nanotechnology, note that nanoparticles, which are 1/50,000th the width of a human hair, are used in products ranging from medicines to cosmetics. The particles also could end up in the environment, settling in the soil, especially as fertilizers, growth enhancers and other nanoagricultural products hit the market. Some plants can take-up and accumulate nanoparticles. But it is unclear whether this poses a problem for plants or for the animals (like humans) that eat them. So, the researchers sorted through the scientific literature looking for evidence to settle the safety question.

In the article, the scientists analyzed nearly 100 scientific articles on the effects of different types of nanoparticles on edible plants. They found that the uptake and build-up of nanoparticles varies, and these factors largely depend on the type of plant and the size and chemical composition of the nanoparticles. "This literature review has confirmed that knowledge on plant toxicity of [nanomaterials] is at the foundation stage," the article states, noting that the emerging field of nanoecotoxicology is starting to tackle this topic.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology technology :

1. Environmental Training Center Prepares Companies to Handle Nanotechnology Environmental and Human Safety Impacts
2. Long-term Safety and Effectiveness of Bronchial Thermoplasty Demonstrated in Treating Severe Asthma
3. New material could improve safety for first responders to chemical hazards
4. Tibotec Advances Global Clinical Research Program for TMC435 in HCV; Will Present Four Abstracts Evaluating Safety and Efficacy at EASL
5. Intrasphere Technologies Launches SafetyXpress(TM) for Oracle(R) Argus Safety
6. Top 5 Global Pharmaceutical Company Selects NewCardios QTinno for 2 Upcoming Phase I Drug Safety Trials
7. Intrasphere Technologies Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite
8. NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate
9. Pfizer Stops Clinical Trials of Thelin® and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety
10. Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B
11. Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):